The routine commissioning of Tiotropium bromide monohydrate and olodaterol hydrochloride (Spiolto® Respimat®) combination inhaler is accepted in Devon for chronic obstructive pulmonary disease (COPD).
| Filename: | Tiotropium bromide monohydrate and olodaterol hydrochloride (Spiolto® Respimat®) combination inhaler for Chronic Obstructive Pulmonary Disease |
| Filetype: | |
| Filesize: | 52.33 KB |
| Date uploaded: | 26th September 2017 |
| Date updated: | 8th December 2022 |
